Document is current
Any future updates will be listed below
-
Authors
Kang, Min-Gyu
Choi, Jeong-Hee
Kim, Sang-Heon
Jeong, Tae Bin
Kim, Joo-Young
Kim, Jea-Won
Lee, Chang Youl
- License Information
-
More Information
Article History
Received: 14 June 2024
Accepted: 28 May 2025
First Online: 2 July 2025
Declarations
:
: T.-B. J, J.-Y. K and J.-W. K are full-time employees of GREEN CROSS Wellbeing Co., Ltd., the company that manufactures and markets GCWB1001 used in this study. J.-H. C, M.-G. K, S.-H. K, C.-R. L and S.-H. L declare no competing interests.
: All subjects provided written informed consent. This study was conducted in accordance with the International Conference on Harmonization—Good Clinical Practice (ICH-GCP) guidelines. The study protocol was reviewed and approved by the independent Institutional Review Boards (IRB) of participating institutions: Chungbuk National University Hospital (IRB No: CBNUH 2022-05-011-003), Hallym University Dongtan Sacred Heart Hospital (IRB No: HDT 2022-05-007), Hallym University Chuncheon Sacred Heart Hospital (IRB No: CHUNCHEON 2022-05-006), and Hanyang University Hospital (IRB No: HYUH 2022-05-035). All methods were performed in accordance with the relevant guidelines and regulations. The study was registered at ClinicalTrials.gov under the identifier [NCT05544942].
